Pacira Pharmaceuticals Revenue 2009-2019 | PCRX

Pacira Pharmaceuticals revenue from 2009 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Pacira Pharmaceuticals Annual Revenue (Millions of US $)
2018	$337
2017	$287
2016	$276
2015	$249
2014	$198
2013	$86
2012	$39
2011	$16
2010	$15
2009	$15
2008	$14

Pacira Pharmaceuticals Quarterly Revenue (Millions of US $)
Q1 2019	$91
Q4 2018	$95
Q3 2018	$83
Q2 2018	$84
Q1 2018	$75
Q4 2017	$79
Q3 2017	$67
Q2 2017	$71
Q1 2017	$69
Q4 2016	$73
Q3 2016	$68
Q2 2016	$70
Q1 2016	$65
Q4 2015	$69
Q3 2015	$62
Q2 2015	$59
Q1 2015	$58
Q4 2014	$62
Q3 2014	$52
Q2 2014	$47
Q1 2014	$37
Q4 2013	$34
Q3 2013	$23
Q2 2013	$17
Q1 2013	$12
Q4 2012	$10
Q3 2012	$8
Q2 2012	$12
Q1 2012	$8
Q4 2011	$4
Q3 2011	$4
Q2 2011	$4
Q1 2011	$4
Q4 2010	$2
Q3 2010	$5
Q2 2010	$3
Q1 2010	$5
Q4 2009
Q4 2008

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$1.705B	$0.337B
Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc. is based in New Jersey.

Stock Name	Country	Market Cap	PE Ratio
Zoetis (ZTS)	United States	$54.237B	34.65
Astellas Pharma (ALPMY)	Japan	$28.255B	13.85
Takeda Pharmaceutical (TAK)	Japan	$27.794B	8.16
Eisai (ESALY)	Japan	$16.077B	27.64
UCB SA (UCBJF)	Belgium	$15.866B	0.00
Grifols, S.A (GRFS)	Spain	$14.700B	18.59
Merck (MKGAF)	Germany	$13.435B	18.33
IPSEN SA ADR (IPSEY)	France	$10.629B	0.00
Sage Therapeutics (SAGE)	United States	$9.716B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$9.254B	19.78
Ionis Pharmaceuticals (IONS)	United States	$9.194B	20.10
Neurocrine Biosciences (NBIX)	United States	$7.823B	0.00
Catalent (CTLT)	United States	$7.787B	31.25
Jazz Pharmaceuticals (JAZZ)	Ireland	$7.540B	10.34
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$7.257B	19.83
Nektar Therapeutics (NKTR)	United States	$5.878B	9.58
STADA ARZNEIMI (STDAF)	Germany	$5.634B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$5.420B	0.00
Orion OYJ (ORINY)	Finland	$5.275B	24.34
Hypermarcas (HYPMY)	Brazil	$4.944B	17.38
Evotec AG (EVTCY)	Germany	$4.268B	45.82
Tilray (TLRY)	Canada	$4.214B	0.00
FibroGen (FGEN)	United States	$3.929B	0.00
United Therapeutics (UTHR)	United States	$3.351B	0.00
Taro Pharmaceutical Industries (TARO)	Israel	$3.195B	11.47
Arrowhead Pharmaceuticals (ARWR)	United States	$2.574B	387.86
PTC Therapeutics (PTCT)	United States	$2.510B	0.00
Xencor (XNCR)	United States	$2.499B	68.21
Zogenix (ZGNX)	United States	$1.999B	0.00
Portola Pharmaceuticals (PTLA)	United States	$1.776B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$1.669B	22.80
Ironwood Pharmaceuticals (IRWD)	United States	$1.618B	0.00
CLINIGEN GP (CLIGF)	United Kingdom	$1.577B	0.00
Heron Therapeutics (HRTX)	United States	$1.467B	0.00
USANA Health Sciences (USNA)	United States	$1.394B	12.12
Corcept Therapeutics (CORT)	United States	$1.220B	17.41
ArQule (ARQL)	United States	$1.211B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.202B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$1.105B	3.98
Radius Health (RDUS)	United States	$1.024B	0.00
Theravance Biopharma (TBPH)	Cayman Islands	$0.973B	0.00
Endo (ENDP)	Ireland	$0.927B	1.49
Spectrum Pharmaceuticals (SPPI)	United States	$0.904B	0.00
Concordia (CXRXF)	Canada	$0.729B	0.00
Organogenesis Holdings (ORGO)	United States	$0.707B	0.00
Aptorum Group (APM)	China	$0.672B	0.00
TherapeuticsMD (TXMD)	United States	$0.603B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.594B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$0.581B	0.00
GlycoMimetics (GLYC)	United States	$0.547B	0.00
Translate Bio (TBIO)	United States	$0.517B	0.00
Akebia Therapeutics (AKBA)	United States	$0.496B	0.00
ChemoCentryx (CCXI)	United States	$0.493B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.489B	0.00
Dova Pharmaceuticals (DOVA)	United States	$0.480B	0.00
Dermira (DERM)	United States	$0.470B	0.00
Siga Technologies (SIGA)	United States	$0.464B	1.09
BioSpecifics Technologies Corp (BSTC)	United States	$0.458B	23.09
Indivior (INVVY)	United States	$0.434B	1.57
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.426B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.421B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$0.419B	0.00
CV Sciences (CVSI)	United States	$0.416B	0.00
Flexion Therapeutics (FLXN)	United States	$0.410B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.400B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$0.397B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.381B	0.00
Innate Pharma SA (IPHYF)	France	$0.366B	0.00
ImmunoGen (IMGN)	United States	$0.365B	0.00
Harpoon Therapeutics (HARP)	United States	$0.365B	0.00
CannTrust Holdings (CTST)	Canada	$0.364B	0.00
OptiNose (OPTN)	United States	$0.330B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.321B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.299B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.272B	0.00
Molecular Templates (MTEM)	United States	$0.268B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.260B	0.00
Aratana Therapeutics (PETX)	United States	$0.244B	0.00
Lannett Co Inc (LCI)	United States	$0.228B	2.22
Recro Pharma (REPH)	United States	$0.223B	0.00
Ocular Therapeutix (OCUL)	United States	$0.221B	0.00
AcelRx Pharmaceuticals (ACRX)	United States	$0.219B	0.00
ASSERTIO THERAPEUTICS, INC (ASRT)	United States	$0.201B	0.00
IMV INC (IMV)	Canada	$0.193B	0.00
Nature's Sunshine Products (NATR)	United States	$0.169B	54.69
Calithera Biosciences (CALA)	United States	$0.167B	0.00
Redhill Biopharma (RDHL)	Israel	$0.162B	0.00
Taiwan Liposome (TLC)	Taiwan	$0.161B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.160B	0.00
Ardelyx (ARDX)	United States	$0.159B	0.00
MEI Pharma (MEIP)	United States	$0.148B	0.00
Jounce Therapeutics (JNCE)	United States	$0.146B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.143B	0.00
Majesco Entertainment (PTE)	United States	$0.139B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.128B	0.00
DURECT (DRRX)	United States	$0.107B	0.00
Aquestive Therapeutics (AQST)	United States	$0.107B	0.00
Generex Biotechnology (GNBT)	United States	$0.099B	0.00
RENEURON GP (RNUGF)	United Kingdom	$0.094B	0.00
Infinity Pharmaceuticals (INFI)	United States	$0.094B	0.00
Mast Therapeutics (SVRA)	United States	$0.093B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.093B	0.00
Champions Oncology (CSBR)	United States	$0.092B	0.00
Capnia (SLNO)	United States	$0.091B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.090B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.088B	63.00
MediWound (MDWD)	Israel	$0.087B	0.00
Genocea Biosciences (GNCA)	United States	$0.087B	0.00
Natural Alternatives (NAII)	United States	$0.084B	8.40
Avadel Pharmaceuticals (AVDL)	Ireland	$0.083B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.083B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.083B	0.00
Cardiome Pharma (CORV)	Canada	$0.082B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.079B	0.00
Nivalis Therapeutics (ALPN)	United States	$0.078B	0.00
Otonomy (OTIC)	United States	$0.077B	0.00
Novan (NOVN)	United States	$0.074B	0.00
Neos Therapeutics (NEOS)	United States	$0.072B	0.00
Pharmaxis (PXSLY)	Australia	$0.071B	0.00
SCYNEXIS (SCYX)	United States	$0.069B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.066B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.059B	0.00
Melinta Therapeutics (MLNT)	United States	$0.054B	0.00
Medicure (MCUJF)	Canada	$0.054B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.051B	0.00